HELLP Syndrome: Microangiopathic Haemolysis, Hepatic Injury, and Coagulopathy in Pregnancy
HELLP (Haemolysis, Elevated Liver enzymes, and Low Platelets) syndrome is a severe pregnancy-related condition characterised by haemolysis, elevated liver enzymes, and low platelet count. It is considered a variant or complication of pre-eclampsia but represents a distinct and particularly dangerous form of systemic endothelial and microvascular injury. Clinical deterioration can be rapid, with laboratory abnormalities preceding overt hypertension.
What You Need to Know
HELLP syndrome develops as a severe manifestation of placental-driven endothelial dysfunction, sharing its origin with pre-eclampsia but progressing toward more extensive microvascular and haematological injury. Abnormal placental signalling triggers widespread endothelial activation, inflammation, and coagulation pathway disturbance. Rather than remaining confined to blood pressure regulation or renal involvement, vascular injury becomes systemic, affecting red blood cells, platelets, and hepatic circulation simultaneously.
As blood flows through damaged small vessels, shear stress fragments red blood cells and activates platelets, while hepatic sinusoids become obstructed by microthrombi and endothelial swelling. Several linked processes explain the characteristic triad:
Red cell fragmentation occurs as erythrocytes are forced through narrowed, injured microvasculature, producing haemolysis
Platelets are consumed at sites of endothelial injury, leading to thrombocytopenia
Hepatic perfusion is impaired by microvascular obstruction, resulting in hepatocellular injury and enzyme release
The clinical syndrome therefore represents a form of pregnancy-associated thrombotic microangiopathy rather than primary liver disease or isolated coagulation abnormality. Liver involvement arises from ischaemia and sinusoidal obstruction, not infection or biliary pathology, while haemolysis reflects mechanical vascular injury rather than immune destruction. Because these processes evolve rapidly and reinforce one another, HELLP syndrome can deteriorate abruptly, even when preceding hypertension or proteinuria has been mild or absent.
Beyond the Basics
Endothelial injury and microangiopathy
HELLP syndrome is driven by severe endothelial injury triggered by placental-derived inflammatory and anti-angiogenic factors. Damage to the maternal endothelium is most pronounced in small vessels, where loss of normal antithrombotic function causes narrowing, irregular flow, and increased shear stress. The microcirculation shifts toward platelet activation and fibrin deposition, creating a diffuse microangiopathic state that links all components of the syndrome rather than representing separate liver or blood disorders.
Haemolysis and red blood cell destruction
As red blood cells pass through narrowed, fibrin-lined microvessels, they are exposed to abnormal mechanical forces and fragment within the circulation. This intravascular haemolysis reduces effective red cell mass and releases haemoglobin breakdown products into the plasma. These products contribute to oxidative stress, which further damages endothelium and amplifies vascular injury. Laboratory markers of haemolysis often appear early, signalling microvascular failure before overt clinical deterioration.
Platelet consumption and coagulopathy
Platelets adhere to injured endothelial surfaces and are incorporated into microthrombi throughout the circulation. Consumption exceeds platelet production, resulting in thrombocytopenia driven by accelerated use rather than impaired synthesis. Reduced platelet availability compromises haemostatic reserve and increases bleeding risk, particularly during delivery or operative intervention. This consumption-based mechanism distinguishes HELLP syndrome from isolated gestational thrombocytopenia, where endothelial injury is absent.
Hepatic ischaemia and enzyme elevation
The liver is highly susceptible to microvascular injury due to its dense sinusoidal network. Endothelial swelling and microthrombus formation reduce hepatic perfusion, leading to ischaemic hepatocellular injury and leakage of transaminases into the circulation. Oedema or haemorrhage within hepatic tissue stretches the liver capsule, producing right upper quadrant or epigastric pain. In severe cases, ongoing vascular compromise may progress to subcapsular haematoma or hepatic rupture, reflecting catastrophic failure of hepatic microcirculation rather than primary liver pathology.
Interaction with hypertension and pre-eclampsia
Although HELLP syndrome frequently occurs in association with pre-eclampsia, hypertension may be mild, late, or initially absent. Disease severity correlates more closely with the extent of endothelial and microvascular injury than with absolute blood pressure levels. This explains why HELLP can progress rapidly in patients who appear clinically stable from a hypertensive perspective and why reliance on blood pressure alone may delay diagnosis.
Rapid progression and postpartum persistence
HELLP syndrome may develop antenatally or in the postpartum period, and progression can continue after delivery. Endothelial injury, platelet consumption, and hepatic dysfunction may worsen transiently before recovery begins. This delayed resolution reflects ongoing vascular and inflammatory dysregulation rather than persistent placental signalling alone. Close monitoring remains essential after delivery until laboratory abnormalities and organ function stabilise, as recovery occurs gradually rather than immediately.
Clinical Connections
HELLP syndrome often presents with vague, non-specific symptoms such as malaise, nausea, vomiting, headache, or visual disturbance, which may initially resemble common pregnancy-related complaints. Right upper quadrant or epigastric pain is a particularly important feature, as it reflects hepatic capsular stretch from microvascular injury and oedema rather than gastrointestinal pathology. Because clinical features may be subtle or fluctuating, laboratory abnormalities frequently provide the first clear indication of disease progression.
Several findings signal evolving multisystem microvascular injury rather than isolated organ dysfunction:
Evidence of haemolysis from red cell fragmentation within damaged microvessels
Falling platelet counts due to consumption within microthrombi
Rising liver enzymes indicating hepatic ischaemia and cellular injury
Management is therefore centred on maternal stabilisation rather than symptom control alone. Correction of coagulopathy and thrombocytopenia is critical to reduce bleeding risk, particularly around delivery or surgical intervention. Blood pressure control and seizure prophylaxis may be required, but definitive management depends on timely delivery to remove the source of endothelial activation. Delay allows ongoing microvascular injury, increasing the risk of hepatic rupture, massive haemorrhage, acute kidney injury, and maternal death. Early recognition and escalation of care are essential to interrupt disease progression and protect maternal organ function.
Concept Check
How does endothelial injury lead to red blood cell fragmentation in HELLP syndrome?
Why are platelets consumed rather than underproduced?
How does hepatic microvascular injury elevate liver enzymes?
Why can HELLP syndrome occur without severe hypertension?
Why may HELLP worsen temporarily after delivery?